As a VFS team member I want to conduct Toxic Exposure usability research so that I know how Veterans feel when completing the Toxic Exposure pages in the 526 form.
Acceptance Criteria
[ ] What will be created or happen as a result of this story?
Additional Information
Some expectations and targets dates for sharing results:
Sprint 12
December 4 - December 17
Conduct moderated usability tests (with veterans who use assistive technology and veterans who do not use assistive technology) on the 1.1 TE release in production or staging environment.
Collect and synthesize data, analyze for trends
Provide Shannon and Emily with an initial summary of results after testing each cohort.
Sprint 13
December 18 - December 31
Sprint 13 will be a 3 week Sprint, from December 18, 2024 – January 7, 2025
Write topline insights report
Final synthesis and reporting will be completed before year-end, along with two share-out sessions:
A session with the OCTO enabling team and VBA.An open-invite session for the Benefits portfolio and health team, or alternatively, a recorded share-out.
FY Q2 2025
We will present in the OCTO Research Share-out. To secure a spot, we’ll request to be added to the waiting list before the end of 2024, as scheduling can take several months.
Description
As a VFS team member I want to conduct Toxic Exposure usability research so that I know how Veterans feel when completing the Toxic Exposure pages in the 526 form.
Acceptance Criteria
Additional Information
Some expectations and targets dates for sharing results:
Sprint 12
December 4 - December 17 Conduct moderated usability tests (with veterans who use assistive technology and veterans who do not use assistive technology) on the 1.1 TE release in production or staging environment. Collect and synthesize data, analyze for trends Provide Shannon and Emily with an initial summary of results after testing each cohort.
Sprint 13
December 18 - December 31 Sprint 13 will be a 3 week Sprint, from December 18, 2024 – January 7, 2025 Write topline insights report Final synthesis and reporting will be completed before year-end, along with two share-out sessions: A session with the OCTO enabling team and VBA. An open-invite session for the Benefits portfolio and health team, or alternatively, a recorded share-out.
FY Q2 2025
We will present in the OCTO Research Share-out. To secure a spot, we’ll request to be added to the waiting list before the end of 2024, as scheduling can take several months.